

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin biosynthetic process (GO:0042438) | 8.04129698 |
| 2 | melanin metabolic process (GO:0006582) | 7.43564019 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.58195500 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.39383801 |
| 5 | secondary metabolite biosynthetic process (GO:0044550) | 6.31335260 |
| 6 | synaptic vesicle maturation (GO:0016188) | 6.29452687 |
| 7 | locomotory exploration behavior (GO:0035641) | 6.16947807 |
| 8 | vocalization behavior (GO:0071625) | 5.94200902 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.83535164 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 5.60283803 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.52497919 |
| 12 | glutamate secretion (GO:0014047) | 5.49287033 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.47840239 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.47322079 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.12547122 |
| 16 | protein localization to synapse (GO:0035418) | 5.10580148 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.06496258 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.02746468 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.00433715 |
| 20 | exploration behavior (GO:0035640) | 4.77352309 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.76876091 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 4.63645471 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.59492379 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.58029885 |
| 25 | cell migration in hindbrain (GO:0021535) | 4.54417355 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.53080789 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.51383408 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.49815245 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 4.47158075 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 4.46962781 |
| 31 | neuron cell-cell adhesion (GO:0007158) | 4.36995682 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 4.32365432 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.29928109 |
| 34 | long-term memory (GO:0007616) | 4.27968112 |
| 35 | positive regulation of membrane potential (GO:0045838) | 4.24881647 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 4.24553414 |
| 37 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.18520684 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 4.03596182 |
| 39 | regulation of synaptic plasticity (GO:0048167) | 4.03482132 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.98233034 |
| 41 | positive regulation of synapse maturation (GO:0090129) | 3.86576555 |
| 42 | gamma-aminobutyric acid transport (GO:0015812) | 3.81617068 |
| 43 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.79220390 |
| 44 | proline transport (GO:0015824) | 3.72136536 |
| 45 | long-term synaptic potentiation (GO:0060291) | 3.71908867 |
| 46 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.71062826 |
| 47 | semaphorin-plexin signaling pathway (GO:0071526) | 3.68298306 |
| 48 | neuromuscular process controlling balance (GO:0050885) | 3.67249781 |
| 49 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.64813598 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.58694682 |
| 51 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.58192692 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.57979495 |
| 53 | cell-cell junction maintenance (GO:0045217) | 3.57385042 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.55553306 |
| 55 | cellular potassium ion homeostasis (GO:0030007) | 3.55084308 |
| 56 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.54932440 |
| 57 | neurotransmitter transport (GO:0006836) | 3.53560152 |
| 58 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.52151602 |
| 59 | regulation of dendritic spine development (GO:0060998) | 3.52058978 |
| 60 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.51916838 |
| 61 | dendritic spine organization (GO:0097061) | 3.51130724 |
| 62 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.50546660 |
| 63 | activation of protein kinase A activity (GO:0034199) | 3.48573780 |
| 64 | neuron recognition (GO:0008038) | 3.48154342 |
| 65 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.46937826 |
| 66 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46076908 |
| 67 | positive regulation of dendritic spine development (GO:0060999) | 3.45639899 |
| 68 | melanocyte differentiation (GO:0030318) | 3.44396755 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.41968623 |
| 70 | postsynaptic membrane organization (GO:0001941) | 3.40714635 |
| 71 | behavioral fear response (GO:0001662) | 3.39958046 |
| 72 | behavioral defense response (GO:0002209) | 3.39958046 |
| 73 | auditory behavior (GO:0031223) | 3.39212721 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.38668687 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 3.35711388 |
| 76 | membrane depolarization (GO:0051899) | 3.33233760 |
| 77 | regulation of neurotransmitter levels (GO:0001505) | 3.32058942 |
| 78 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.31323427 |
| 79 | learning (GO:0007612) | 3.30166492 |
| 80 | chondroitin sulfate catabolic process (GO:0030207) | 3.29170387 |
| 81 | regulation of neurotransmitter transport (GO:0051588) | 3.28343202 |
| 82 | pigment cell differentiation (GO:0050931) | 3.24749901 |
| 83 | response to auditory stimulus (GO:0010996) | 3.23395867 |
| 84 | protein retention in ER lumen (GO:0006621) | 3.23382914 |
| 85 | neuronal ion channel clustering (GO:0045161) | 3.22190299 |
| 86 | axonal fasciculation (GO:0007413) | 3.22108271 |
| 87 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.21291309 |
| 88 | sodium ion export (GO:0071436) | 3.20787360 |
| 89 | prepulse inhibition (GO:0060134) | 3.20778098 |
| 90 | positive regulation of synaptic transmission (GO:0050806) | 3.20345471 |
| 91 | response to histamine (GO:0034776) | 3.20210054 |
| 92 | amino acid import (GO:0043090) | 3.19620536 |
| 93 | regulation of synaptic transmission (GO:0050804) | 3.18560974 |
| 94 | cerebellar Purkinje cell layer development (GO:0021680) | 3.17611201 |
| 95 | neuromuscular process controlling posture (GO:0050884) | 3.16814404 |
| 96 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.16189205 |
| 97 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15818765 |
| 98 | positive regulation of fibroblast migration (GO:0010763) | 3.15140602 |
| 99 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.15056564 |
| 100 | cerebellar granule cell differentiation (GO:0021707) | 3.13610844 |
| 101 | membrane hyperpolarization (GO:0060081) | 3.13151798 |
| 102 | fear response (GO:0042596) | 3.12883514 |
| 103 | neuromuscular process (GO:0050905) | 3.09845010 |
| 104 | establishment of mitochondrion localization (GO:0051654) | 3.09555596 |
| 105 | innervation (GO:0060384) | 3.07599955 |
| 106 | intraspecies interaction between organisms (GO:0051703) | 3.07515963 |
| 107 | social behavior (GO:0035176) | 3.07515963 |
| 108 | chemosensory behavior (GO:0007635) | 3.06221016 |
| 109 | regulation of glutamate secretion (GO:0014048) | 3.05958084 |
| 110 | L-amino acid import (GO:0043092) | 3.05878928 |
| 111 | presynaptic membrane assembly (GO:0097105) | 3.05608080 |
| 112 | synaptic transmission (GO:0007268) | 3.05094450 |
| 113 | regulation of synapse maturation (GO:0090128) | 3.04302861 |
| 114 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.03880479 |
| 115 | dermatan sulfate metabolic process (GO:0030205) | 3.03485886 |
| 116 | membrane depolarization during action potential (GO:0086010) | 3.02224439 |
| 117 | regulation of female receptivity (GO:0045924) | 3.01986331 |
| 118 | long term synaptic depression (GO:0060292) | 3.01760380 |
| 119 | dendrite morphogenesis (GO:0048813) | 3.01211321 |
| 120 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.98513581 |
| 121 | mating behavior (GO:0007617) | 2.96016627 |
| 122 | protein localization to endosome (GO:0036010) | 2.91640035 |
| 123 | mitochondrion transport along microtubule (GO:0047497) | 2.84459982 |
| 124 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.84459982 |
| 125 | dopamine receptor signaling pathway (GO:0007212) | 2.83563790 |
| 126 | positive regulation of protein dephosphorylation (GO:0035307) | 2.81556856 |
| 127 | axon regeneration (GO:0031103) | 2.81362207 |
| 128 | regulation of ARF GTPase activity (GO:0032312) | 2.77702745 |
| 129 | response to dietary excess (GO:0002021) | 2.74469018 |
| 130 | dermatan sulfate biosynthetic process (GO:0030208) | 2.72223227 |
| 131 | basement membrane organization (GO:0071711) | 2.70546197 |
| 132 | neuron projection regeneration (GO:0031102) | 2.69959258 |
| 133 | negative regulation of microtubule polymerization (GO:0031115) | 2.69958565 |
| 134 | cell junction maintenance (GO:0034331) | 2.68479570 |
| 135 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.64128049 |
| 136 | mannose metabolic process (GO:0006013) | 2.62693376 |
| 137 | regulation of early endosome to late endosome transport (GO:2000641) | 2.61515605 |
| 138 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.53827711 |
| 139 | cellular response to catecholamine stimulus (GO:0071870) | 2.53042338 |
| 140 | cellular response to monoamine stimulus (GO:0071868) | 2.53042338 |
| 141 | adherens junction assembly (GO:0034333) | 2.52736894 |
| 142 | barbed-end actin filament capping (GO:0051016) | 2.52520146 |
| 143 | axon extension (GO:0048675) | 2.51101607 |
| 144 | cell communication by electrical coupling (GO:0010644) | 2.50495075 |
| 145 | positive regulation of axon extension (GO:0045773) | 2.49508234 |
| 146 | protein targeting to plasma membrane (GO:0072661) | 2.49149013 |
| 147 | neuron projection extension (GO:1990138) | 2.48698539 |
| 148 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.46725815 |
| 149 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.44682614 |
| 150 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.44363351 |
| 151 | cellular component maintenance (GO:0043954) | 2.43421527 |
| 152 | enteric nervous system development (GO:0048484) | 2.39590327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.45115430 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.71083530 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47458775 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.23739288 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23730729 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13764635 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.99624493 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.96345045 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.86804427 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.86804427 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79318143 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77915094 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.73447456 |
| 14 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.73088200 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.71129578 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57443247 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56696520 |
| 18 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56433538 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55261583 |
| 20 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51325637 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.41585588 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34101820 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33570855 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30116498 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.28555518 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.26173106 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25720282 |
| 28 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.24779543 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.22004298 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.20959987 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.12630937 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.11236477 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10831012 |
| 34 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.08465691 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.07068690 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04083073 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.92041622 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91794027 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81588983 |
| 40 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77676894 |
| 41 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.71980862 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.70658282 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70307769 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69239554 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.68639865 |
| 46 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.67240617 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66810684 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66175683 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65647511 |
| 50 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.61185624 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59925781 |
| 52 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.59179625 |
| 53 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.58013593 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57399009 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.56852691 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56423374 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55511895 |
| 58 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53556979 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49615501 |
| 60 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.46559444 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.45765881 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44894910 |
| 63 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.43509570 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42964960 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.41245474 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40011941 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39031297 |
| 68 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38104760 |
| 69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37996837 |
| 70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.37084895 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33962126 |
| 72 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.33328350 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32593429 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32046361 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.32014768 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31015996 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30013877 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29737258 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28711081 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26778787 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26436039 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25861461 |
| 83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25647713 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25279178 |
| 85 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.25072255 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24683743 |
| 87 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.23379655 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 1.22274577 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20104359 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20034154 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19316126 |
| 92 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17946383 |
| 93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17695419 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16890541 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.15884238 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15266478 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15151682 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14214437 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12780692 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12299516 |
| 101 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.11669257 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11649936 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11582612 |
| 104 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.10155064 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09993413 |
| 106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09967176 |
| 107 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09463363 |
| 108 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08335567 |
| 109 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08145100 |
| 110 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.08090168 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07676617 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07544000 |
| 113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07335506 |
| 114 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06831818 |
| 115 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06763025 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04521408 |
| 117 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03930486 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03698907 |
| 119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03598711 |
| 120 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03381948 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02814629 |
| 122 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02530071 |
| 123 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02462927 |
| 124 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02404025 |
| 125 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01149653 |
| 126 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01143121 |
| 127 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99424756 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99063830 |
| 129 | * ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98409622 |
| 130 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98098159 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98032393 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97425378 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97289599 |
| 134 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96398514 |
| 135 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96284232 |
| 136 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96192960 |
| 137 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95842637 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95553402 |
| 139 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95018822 |
| 140 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94501420 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94174047 |
| 142 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93883462 |
| 143 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92310507 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91569956 |
| 145 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91352679 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89780185 |
| 147 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89373917 |
| 148 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88748549 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88368436 |
| 150 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87373093 |
| 151 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87003511 |
| 152 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86644025 |
| 153 | JUN_21703547_ChIP-Seq_K562_Human | 0.86042455 |
| 154 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86012317 |
| 155 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86012317 |
| 156 | FUS_26573619_Chip-Seq_HEK293_Human | 0.85845235 |
| 157 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83505529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.60770512 |
| 2 | MP0005171_absent_coat_pigmentation | 7.17557597 |
| 3 | MP0003880_abnormal_central_pattern | 4.94915523 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.49377923 |
| 5 | MP0004270_analgesia | 3.80138790 |
| 6 | MP0009745_abnormal_behavioral_response | 3.71455581 |
| 7 | MP0002822_catalepsy | 3.65752988 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.65286980 |
| 9 | MP0000372_irregular_coat_pigmentation | 3.46051893 |
| 10 | MP0003136_yellow_coat_color | 3.35094752 |
| 11 | MP0002064_seizures | 3.32790539 |
| 12 | MP0005257_abnormal_intraocular_pressure | 3.24188600 |
| 13 | MP0004381_abnormal_hair_follicle | 3.13533809 |
| 14 | MP0009046_muscle_twitch | 3.06160439 |
| 15 | MP0001968_abnormal_touch/_nociception | 3.00728713 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.96522117 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.82103243 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.79190221 |
| 19 | MP0001486_abnormal_startle_reflex | 2.69693594 |
| 20 | MP0002272_abnormal_nervous_system | 2.62073307 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.55285411 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.54669898 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.52805292 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.49683570 |
| 25 | MP0000015_abnormal_ear_pigmentation | 2.45155268 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 2.43039397 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.37022165 |
| 28 | MP0002736_abnormal_nociception_after | 2.31023752 |
| 29 | MP0008260_abnormal_autophagy | 2.27978527 |
| 30 | MP0005408_hypopigmentation | 2.25400516 |
| 31 | MP0002735_abnormal_chemical_nociception | 2.09292950 |
| 32 | MP0001440_abnormal_grooming_behavior | 2.08260271 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 2.00512651 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.91969603 |
| 35 | MP0008569_lethality_at_weaning | 1.90624876 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.89989219 |
| 37 | MP0001970_abnormal_pain_threshold | 1.88624708 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.84420377 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.82573995 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.77518137 |
| 41 | MP0004858_abnormal_nervous_system | 1.76901667 |
| 42 | MP0000371_diluted_coat_color | 1.74139185 |
| 43 | MP0000778_abnormal_nervous_system | 1.70525750 |
| 44 | MP0002184_abnormal_innervation | 1.70319836 |
| 45 | MP0003879_abnormal_hair_cell | 1.67500061 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.65800044 |
| 47 | MP0004924_abnormal_behavior | 1.65800044 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.64024292 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.63626642 |
| 50 | MP0003329_amyloid_beta_deposits | 1.60615352 |
| 51 | MP0003787_abnormal_imprinting | 1.57645831 |
| 52 | MP0002089_abnormal_postnatal_growth/wei | 1.57605848 |
| 53 | MP0001849_ear_inflammation | 1.50517808 |
| 54 | MP0002075_abnormal_coat/hair_pigmentati | 1.50053963 |
| 55 | MP0000955_abnormal_spinal_cord | 1.49668215 |
| 56 | MP0003123_paternal_imprinting | 1.43235894 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.41112652 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.37855500 |
| 59 | MP0001984_abnormal_olfaction | 1.36950408 |
| 60 | MP0004885_abnormal_endolymph | 1.35461381 |
| 61 | MP0003633_abnormal_nervous_system | 1.33847592 |
| 62 | MP0001529_abnormal_vocalization | 1.27951348 |
| 63 | MP0003878_abnormal_ear_physiology | 1.25537626 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.25537626 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.25258581 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.24578795 |
| 67 | MP0001186_pigmentation_phenotype | 1.23551140 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.22237916 |
| 69 | MP0001188_hyperpigmentation | 1.20492975 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.18600985 |
| 71 | MP0003075_altered_response_to | 1.18598525 |
| 72 | MP0001905_abnormal_dopamine_level | 1.16662874 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.15957126 |
| 74 | MP0001958_emphysema | 1.14654073 |
| 75 | MP0003631_nervous_system_phenotype | 1.13892727 |
| 76 | MP0004142_abnormal_muscle_tone | 1.10677199 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.10567464 |
| 78 | MP0002152_abnormal_brain_morphology | 1.09541482 |
| 79 | MP0005503_abnormal_tendon_morphology | 1.07217387 |
| 80 | MP0008872_abnormal_physiological_respon | 1.04798189 |
| 81 | MP0001177_atelectasis | 1.03179572 |
| 82 | MP0008874_decreased_physiological_sensi | 1.03055377 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.00036816 |
| 84 | MP0000751_myopathy | 0.99582813 |
| 85 | MP0003279_aneurysm | 0.96809374 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.95391415 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.94967963 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.93888143 |
| 89 | MP0003122_maternal_imprinting | 0.90313503 |
| 90 | MP0003283_abnormal_digestive_organ | 0.89473045 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.88598557 |
| 92 | MP0004272_abnormal_basement_membrane | 0.87618997 |
| 93 | MP0010386_abnormal_urinary_bladder | 0.86742919 |
| 94 | MP0004510_myositis | 0.81431362 |
| 95 | MP0004085_abnormal_heartbeat | 0.81227342 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.80041570 |
| 97 | MP0002229_neurodegeneration | 0.79557695 |
| 98 | MP0005535_abnormal_body_temperature | 0.79445947 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.78613548 |
| 100 | MP0005499_abnormal_olfactory_system | 0.78486319 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.78486319 |
| 102 | MP0005248_abnormal_Harderian_gland | 0.76711109 |
| 103 | MP0001963_abnormal_hearing_physiology | 0.76188857 |
| 104 | MP0003632_abnormal_nervous_system | 0.75971659 |
| 105 | MP0005409_darkened_coat_color | 0.75175333 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 0.74316786 |
| 107 | MP0001324_abnormal_eye_pigmentation | 0.73777964 |
| 108 | MP0004484_altered_response_of | 0.72251239 |
| 109 | MP0001299_abnormal_eye_distance/ | 0.71924418 |
| 110 | MP0005551_abnormal_eye_electrophysiolog | 0.71456502 |
| 111 | MP0003690_abnormal_glial_cell | 0.70838998 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.70715850 |
| 113 | MP0002090_abnormal_vision | 0.70293872 |
| 114 | MP0004742_abnormal_vestibular_system | 0.70113789 |
| 115 | MP0000920_abnormal_myelination | 0.68737013 |
| 116 | MP0002751_abnormal_autonomic_nervous | 0.68382939 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.67559151 |
| 118 | MP0003634_abnormal_glial_cell | 0.66820591 |
| 119 | MP0002249_abnormal_larynx_morphology | 0.65863601 |
| 120 | MP0001664_abnormal_digestion | 0.65848927 |
| 121 | MP0002752_abnormal_somatic_nervous | 0.64555387 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.64384820 |
| 123 | MP0000604_amyloidosis | 0.62565698 |
| 124 | MP0003091_abnormal_cell_migration | 0.61998487 |
| 125 | MP0009278_abnormal_bone_marrow | 0.61591587 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.58253188 |
| 127 | MP0005197_abnormal_uvea_morphology | 0.56665231 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.55669395 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.55492441 |
| 130 | MP0003861_abnormal_nervous_system | 0.55324475 |
| 131 | MP0004215_abnormal_myocardial_fiber | 0.55044569 |
| 132 | MP0002938_white_spotting | 0.54377000 |
| 133 | MP0005508_abnormal_skeleton_morphology | 0.53467734 |
| 134 | MP0010769_abnormal_survival | 0.52938721 |
| 135 | MP0001943_abnormal_respiration | 0.52911084 |
| 136 | MP0010770_preweaning_lethality | 0.49841121 |
| 137 | MP0002082_postnatal_lethality | 0.49841121 |
| 138 | MP0010768_mortality/aging | 0.49705968 |
| 139 | MP0004233_abnormal_muscle_weight | 0.49192611 |
| 140 | MP0003956_abnormal_body_size | 0.48727370 |
| 141 | MP0005166_decreased_susceptibility_to | 0.48028289 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.46665151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.69161920 |
| 2 | Myokymia (HP:0002411) | 7.87848683 |
| 3 | Focal seizures (HP:0007359) | 6.27413095 |
| 4 | Visual hallucinations (HP:0002367) | 5.35942177 |
| 5 | Peripheral hypomyelination (HP:0007182) | 5.33502550 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.16198292 |
| 7 | Febrile seizures (HP:0002373) | 4.90393093 |
| 8 | Atonic seizures (HP:0010819) | 4.77827462 |
| 9 | Ocular albinism (HP:0001107) | 4.71742034 |
| 10 | White forelock (HP:0002211) | 4.57465835 |
| 11 | Absence seizures (HP:0002121) | 4.28455013 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.26915214 |
| 13 | Iris hypopigmentation (HP:0007730) | 4.23888282 |
| 14 | Heterochromia iridis (HP:0001100) | 4.09463457 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 4.08934563 |
| 16 | Dialeptic seizures (HP:0011146) | 3.99432206 |
| 17 | Action tremor (HP:0002345) | 3.94176828 |
| 18 | Patchy hypopigmentation of hair (HP:0011365) | 3.80555783 |
| 19 | Broad-based gait (HP:0002136) | 3.75344272 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.71844503 |
| 21 | Poor eye contact (HP:0000817) | 3.70662932 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.68900031 |
| 23 | Protrusio acetabuli (HP:0003179) | 3.64485725 |
| 24 | Distal upper limb amyotrophy (HP:0007149) | 3.46750234 |
| 25 | Upper limb amyotrophy (HP:0009129) | 3.46750234 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.39863279 |
| 27 | Hand muscle atrophy (HP:0009130) | 3.38648580 |
| 28 | Depression (HP:0000716) | 3.38597967 |
| 29 | Amblyopia (HP:0000646) | 3.33592479 |
| 30 | Ankle clonus (HP:0011448) | 3.31795453 |
| 31 | Impaired social interactions (HP:0000735) | 3.29567803 |
| 32 | Abnormal social behavior (HP:0012433) | 3.29567803 |
| 33 | Hyperventilation (HP:0002883) | 3.26427160 |
| 34 | Dysmetria (HP:0001310) | 3.24828274 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 3.13064940 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.11972032 |
| 37 | Hypopigmentation of the fundus (HP:0007894) | 3.09447855 |
| 38 | Anxiety (HP:0000739) | 3.08675528 |
| 39 | Postural instability (HP:0002172) | 3.05920774 |
| 40 | Papilledema (HP:0001085) | 3.02773348 |
| 41 | Truncal ataxia (HP:0002078) | 2.98128187 |
| 42 | Abnormality of the lower motor neuron (HP:0002366) | 2.95975309 |
| 43 | Impaired smooth pursuit (HP:0007772) | 2.93313341 |
| 44 | Mutism (HP:0002300) | 2.92475390 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.90107997 |
| 46 | Annular pancreas (HP:0001734) | 2.87477692 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.85927242 |
| 48 | Torticollis (HP:0000473) | 2.85669836 |
| 49 | Hyperacusis (HP:0010780) | 2.81968570 |
| 50 | Focal dystonia (HP:0004373) | 2.77673150 |
| 51 | J-shaped sella turcica (HP:0002680) | 2.76954580 |
| 52 | Stereotypic behavior (HP:0000733) | 2.76464743 |
| 53 | Cerebral aneurysm (HP:0004944) | 2.74602781 |
| 54 | Genetic anticipation (HP:0003743) | 2.73427654 |
| 55 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.72207509 |
| 56 | Urinary urgency (HP:0000012) | 2.68079004 |
| 57 | Excessive salivation (HP:0003781) | 2.63973969 |
| 58 | Drooling (HP:0002307) | 2.63973969 |
| 59 | Impaired vibratory sensation (HP:0002495) | 2.55414234 |
| 60 | Bradykinesia (HP:0002067) | 2.55067539 |
| 61 | Scanning speech (HP:0002168) | 2.54518244 |
| 62 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.53537082 |
| 63 | Akinesia (HP:0002304) | 2.53371834 |
| 64 | Hemiparesis (HP:0001269) | 2.52551319 |
| 65 | Hypoplasia of the iris (HP:0007676) | 2.52474033 |
| 66 | Hypoplasia of the fovea (HP:0007750) | 2.52167880 |
| 67 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.52167880 |
| 68 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.52097446 |
| 69 | Cerebral hypomyelination (HP:0006808) | 2.51876761 |
| 70 | Hemiplegia (HP:0002301) | 2.48636931 |
| 71 | Intention tremor (HP:0002080) | 2.46453853 |
| 72 | Absent speech (HP:0001344) | 2.45522020 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.45413959 |
| 74 | Dysmetric saccades (HP:0000641) | 2.45136435 |
| 75 | Progressive inability to walk (HP:0002505) | 2.44112745 |
| 76 | Shallow orbits (HP:0000586) | 2.43844875 |
| 77 | Vertebral compression fractures (HP:0002953) | 2.41301610 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.40027357 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.39235669 |
| 80 | Megalencephaly (HP:0001355) | 2.38841218 |
| 81 | Spastic gait (HP:0002064) | 2.35356918 |
| 82 | Fetal akinesia sequence (HP:0001989) | 2.34479572 |
| 83 | Craniofacial dystonia (HP:0012179) | 2.34261568 |
| 84 | Stridor (HP:0010307) | 2.33652580 |
| 85 | Status epilepticus (HP:0002133) | 2.33479084 |
| 86 | Pointed chin (HP:0000307) | 2.33255389 |
| 87 | Apathy (HP:0000741) | 2.31188498 |
| 88 | Ulnar claw (HP:0001178) | 2.30182539 |
| 89 | Diplopia (HP:0000651) | 2.27029787 |
| 90 | Abnormality of binocular vision (HP:0011514) | 2.27029787 |
| 91 | Biconcave vertebral bodies (HP:0004586) | 2.26675510 |
| 92 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26205408 |
| 93 | Diminished motivation (HP:0000745) | 2.25949643 |
| 94 | Hypoventilation (HP:0002791) | 2.22527397 |
| 95 | Incomplete penetrance (HP:0003829) | 2.22165865 |
| 96 | Ankyloglossia (HP:0010296) | 2.20562734 |
| 97 | Generalized myoclonic seizures (HP:0002123) | 2.19592275 |
| 98 | Cerebral inclusion bodies (HP:0100314) | 2.17430248 |
| 99 | Lower limb amyotrophy (HP:0007210) | 2.17066833 |
| 100 | Genu recurvatum (HP:0002816) | 2.16302836 |
| 101 | Hypsarrhythmia (HP:0002521) | 2.14855611 |
| 102 | Resting tremor (HP:0002322) | 2.13718421 |
| 103 | Bundle branch block (HP:0011710) | 2.12878865 |
| 104 | Premature graying of hair (HP:0002216) | 2.11799227 |
| 105 | Mild short stature (HP:0003502) | 2.11434745 |
| 106 | Inability to walk (HP:0002540) | 2.11277543 |
| 107 | Ulnar bowing (HP:0003031) | 2.11061136 |
| 108 | Neurofibrillary tangles (HP:0002185) | 2.07529218 |
| 109 | Hammertoe (HP:0001765) | 2.04155614 |
| 110 | Insidious onset (HP:0003587) | 2.02517491 |
| 111 | Termporal pattern (HP:0011008) | 2.02517491 |
| 112 | Lower limb muscle weakness (HP:0007340) | 2.01196989 |
| 113 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.00044934 |
| 114 | Absent epiphyses (HP:0010577) | 2.00044934 |
| 115 | Achilles tendon contracture (HP:0001771) | 1.99590452 |
| 116 | Generalized hypopigmentation (HP:0007513) | 1.98905967 |
| 117 | Alacrima (HP:0000522) | 1.97957918 |
| 118 | Distal sensory impairment (HP:0002936) | 1.97838275 |
| 119 | Lower limb asymmetry (HP:0100559) | 1.96956284 |
| 120 | Atrophic scars (HP:0001075) | 1.96735255 |
| 121 | Bladder diverticulum (HP:0000015) | 1.95550435 |
| 122 | Gait ataxia (HP:0002066) | 1.94667943 |
| 123 | Abnormality of dentin (HP:0010299) | 1.94411044 |
| 124 | Mitral regurgitation (HP:0001653) | 1.93077843 |
| 125 | Dysostosis multiplex (HP:0000943) | 1.92739275 |
| 126 | Wormian bones (HP:0002645) | 1.91462491 |
| 127 | Abnormality of the fovea (HP:0000493) | 1.89602154 |
| 128 | Foot dorsiflexor weakness (HP:0009027) | 1.88651579 |
| 129 | Turricephaly (HP:0000262) | 1.88637217 |
| 130 | Abnormal EKG (HP:0003115) | 1.88219248 |
| 131 | Protruding tongue (HP:0010808) | 1.87353768 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.86677734 |
| 133 | Decreased motor nerve conduction velocity (HP:0003431) | 1.85336963 |
| 134 | Delusions (HP:0000746) | 1.84567582 |
| 135 | Insomnia (HP:0100785) | 1.83956309 |
| 136 | Abnormality of salivation (HP:0100755) | 1.83013755 |
| 137 | Blue irides (HP:0000635) | 1.81954953 |
| 138 | Abnormality of the corticospinal tract (HP:0002492) | 1.81689898 |
| 139 | Bell-shaped thorax (HP:0001591) | 1.80173681 |
| 140 | Ankle contracture (HP:0006466) | 1.79546695 |
| 141 | Nuclear cataract (HP:0100018) | 1.79357485 |
| 142 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79211632 |
| 143 | Spinal canal stenosis (HP:0003416) | 1.79200745 |
| 144 | Inappropriate behavior (HP:0000719) | 1.78280680 |
| 145 | Limb dystonia (HP:0002451) | 1.78192042 |
| 146 | Spastic paraparesis (HP:0002313) | 1.77227192 |
| 147 | Broad face (HP:0000283) | 1.76807053 |
| 148 | Polyphagia (HP:0002591) | 1.76454508 |
| 149 | Abnormality of the periventricular white matter (HP:0002518) | 1.76436426 |
| 150 | Morphological abnormality of the inner ear (HP:0011390) | 1.76354855 |
| 151 | Cervical subluxation (HP:0003308) | 1.75974178 |
| 152 | Fragile skin (HP:0001030) | 1.74852538 |
| 153 | Spinal rigidity (HP:0003306) | 1.73060023 |
| 154 | Sleep apnea (HP:0010535) | 1.72930868 |
| 155 | Deeply set eye (HP:0000490) | 1.72727767 |
| 156 | Upper limb muscle weakness (HP:0003484) | 1.72168631 |
| 157 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71965617 |
| 158 | Abnormality of saccadic eye movements (HP:0000570) | 1.71316073 |
| 159 | Onion bulb formation (HP:0003383) | 1.71285552 |
| 160 | Rapidly progressive (HP:0003678) | 1.68903163 |
| 161 | Clonus (HP:0002169) | 1.68594533 |
| 162 | Bowel diverticulosis (HP:0005222) | 1.67349454 |
| 163 | Neuronal loss in central nervous system (HP:0002529) | 1.66946594 |
| 164 | Rigidity (HP:0002063) | 1.65408271 |
| 165 | Increased cerebral lipofuscin (HP:0011813) | 1.65349637 |
| 166 | Abnormality of the foot musculature (HP:0001436) | 1.64973098 |
| 167 | Thickened helices (HP:0000391) | 1.64565769 |
| 168 | Intellectual disability, profound (HP:0002187) | 1.64513266 |
| 169 | Specific learning disability (HP:0001328) | 1.64050268 |
| 170 | Increased connective tissue (HP:0009025) | 1.63662753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.47803833 |
| 2 | NTRK3 | 4.77199885 |
| 3 | MAP3K9 | 3.97450288 |
| 4 | TRIB3 | 3.50625325 |
| 5 | DAPK2 | 3.06771511 |
| 6 | MAP3K4 | 2.66336063 |
| 7 | MINK1 | 2.58377204 |
| 8 | MARK1 | 2.43296742 |
| 9 | PRKD3 | 2.41626322 |
| 10 | MAP2K7 | 2.29112217 |
| 11 | KSR2 | 2.28726829 |
| 12 | PAK6 | 2.25828368 |
| 13 | RIPK4 | 2.22619795 |
| 14 | TAOK2 | 2.13266405 |
| 15 | ICK | 2.13030552 |
| 16 | SIK1 | 1.99048238 |
| 17 | DAPK1 | 1.99029562 |
| 18 | CAMKK1 | 1.91889012 |
| 19 | NTRK2 | 1.88527798 |
| 20 | PRPF4B | 1.85134435 |
| 21 | MAP3K11 | 1.83804352 |
| 22 | KSR1 | 1.78830363 |
| 23 | MAP3K12 | 1.73673954 |
| 24 | MAP2K4 | 1.70917484 |
| 25 | TNIK | 1.67787869 |
| 26 | NTRK1 | 1.63486189 |
| 27 | CDK5 | 1.58882226 |
| 28 | ARAF | 1.57577325 |
| 29 | TESK1 | 1.53627338 |
| 30 | CASK | 1.50814369 |
| 31 | MAP3K13 | 1.50177721 |
| 32 | PLK2 | 1.48606446 |
| 33 | CDK19 | 1.46244256 |
| 34 | PKN2 | 1.39114298 |
| 35 | STK38 | 1.35430871 |
| 36 | FES | 1.32558207 |
| 37 | PRKD2 | 1.28165254 |
| 38 | SIK2 | 1.26776587 |
| 39 | GRK5 | 1.26592213 |
| 40 | PRKCG | 1.23938602 |
| 41 | SIK3 | 1.21265126 |
| 42 | TYRO3 | 1.20071892 |
| 43 | PNCK | 1.20066791 |
| 44 | RPS6KA2 | 1.17993781 |
| 45 | EEF2K | 1.17861681 |
| 46 | PDGFRA | 1.17270539 |
| 47 | TAOK1 | 1.15812292 |
| 48 | MAPK13 | 1.15021130 |
| 49 | MAP3K2 | 1.07386729 |
| 50 | CAMK1 | 1.07384276 |
| 51 | RAF1 | 1.06276470 |
| 52 | SMG1 | 1.04066125 |
| 53 | PTK2B | 1.02602427 |
| 54 | ERN1 | 0.97503766 |
| 55 | CAMK2A | 0.96992832 |
| 56 | UHMK1 | 0.96422772 |
| 57 | BMPR2 | 0.94496445 |
| 58 | CDK18 | 0.92936655 |
| 59 | CDK15 | 0.91168050 |
| 60 | MAP2K6 | 0.90198768 |
| 61 | STK11 | 0.89391626 |
| 62 | MAPK12 | 0.87831942 |
| 63 | EPHB1 | 0.87521993 |
| 64 | PRKCH | 0.85844753 |
| 65 | CDK14 | 0.85446278 |
| 66 | CAMKK2 | 0.84957985 |
| 67 | LATS2 | 0.83716663 |
| 68 | SGK494 | 0.82652738 |
| 69 | SGK223 | 0.82652738 |
| 70 | CAMK2B | 0.82034238 |
| 71 | PTK2 | 0.81886400 |
| 72 | CDK11A | 0.79950390 |
| 73 | PINK1 | 0.79291222 |
| 74 | ALK | 0.78093263 |
| 75 | SGK2 | 0.76757659 |
| 76 | PDK1 | 0.75841807 |
| 77 | SGK1 | 0.73015180 |
| 78 | MARK2 | 0.70077001 |
| 79 | PAK4 | 0.68557706 |
| 80 | SGK3 | 0.66738791 |
| 81 | RET | 0.66541962 |
| 82 | BMX | 0.66393479 |
| 83 | TESK2 | 0.66324039 |
| 84 | OXSR1 | 0.66237772 |
| 85 | PDPK1 | 0.65786843 |
| 86 | LIMK1 | 0.65326280 |
| 87 | MAP4K1 | 0.65037548 |
| 88 | DYRK1A | 0.63059708 |
| 89 | PAK3 | 0.61230494 |
| 90 | MAP3K1 | 0.61180681 |
| 91 | DAPK3 | 0.60108911 |
| 92 | TNK2 | 0.59506964 |
| 93 | MAP3K10 | 0.59221788 |
| 94 | TTN | 0.58764360 |
| 95 | PHKG1 | 0.55048461 |
| 96 | PHKG2 | 0.55048461 |
| 97 | NME1 | 0.54815055 |
| 98 | NEK6 | 0.53848026 |
| 99 | MTOR | 0.53604375 |
| 100 | PRKD1 | 0.53301895 |
| 101 | MAP2K3 | 0.53030248 |
| 102 | CAMK4 | 0.51949091 |
| 103 | MAPK7 | 0.50076757 |
| 104 | PTK6 | 0.49338182 |
| 105 | PRKG2 | 0.49194558 |
| 106 | MAP3K7 | 0.48851407 |
| 107 | CCNB1 | 0.48564667 |
| 108 | DMPK | 0.48334331 |
| 109 | RPS6KA3 | 0.47826837 |
| 110 | IRAK2 | 0.47743227 |
| 111 | CDK12 | 0.47707687 |
| 112 | NME2 | 0.46524957 |
| 113 | PAK2 | 0.46425476 |
| 114 | PRKCZ | 0.46421084 |
| 115 | ROCK2 | 0.46252188 |
| 116 | BRAF | 0.45741539 |
| 117 | FGR | 0.44691254 |
| 118 | CSNK1G2 | 0.44373680 |
| 119 | LMTK2 | 0.43569593 |
| 120 | FYN | 0.43425604 |
| 121 | GRK6 | 0.42765591 |
| 122 | PRKCE | 0.42571287 |
| 123 | CDC42BPA | 0.42085070 |
| 124 | DYRK1B | 0.41250534 |
| 125 | MAP2K1 | 0.41001002 |
| 126 | MAPK10 | 0.40105739 |
| 127 | RPS6KC1 | 0.38535319 |
| 128 | RPS6KL1 | 0.38535319 |
| 129 | BLK | 0.37844019 |
| 130 | CAMK2G | 0.37458551 |
| 131 | MAP3K6 | 0.37419698 |
| 132 | MAP2K2 | 0.37399506 |
| 133 | DDR2 | 0.35956836 |
| 134 | CAMK1G | 0.35655851 |
| 135 | BRSK1 | 0.35200848 |
| 136 | AKT3 | 0.34961808 |
| 137 | CAMK2D | 0.34954943 |
| 138 | RIPK1 | 0.34412496 |
| 139 | FER | 0.33858927 |
| 140 | NEK1 | 0.33678803 |
| 141 | MOS | 0.32358053 |
| 142 | SCYL2 | 0.30018356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.67059641 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21623199 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.02534352 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.83989161 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79039594 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66325609 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64301981 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64097747 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60584353 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.57264112 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.27818339 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.17326627 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13424287 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.01335822 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96972826 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.95683319 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.95569319 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86199757 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79543630 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.72393756 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71076601 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.69469667 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.66873238 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.65880982 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.63073103 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58637740 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.53155483 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43309659 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41614407 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39597726 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.36312599 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35121085 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33441209 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.30143261 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28447363 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24567989 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23735250 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19338799 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16371075 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14502498 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.11711098 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11436574 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11344175 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10388235 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10051250 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09874311 |
| 47 | Axon guidance_Homo sapiens_hsa04360 | 1.07651671 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07413983 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05700181 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03007387 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00366780 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.99010251 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92438355 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92371750 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92193231 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91979070 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91482381 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90842362 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90826440 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.87292536 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86923698 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84152960 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83301060 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81237866 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81021669 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78154388 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76272156 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76027974 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75925109 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.75808856 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75078792 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74789662 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73215918 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69854099 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67191277 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67157505 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66893968 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66870295 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66787851 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66612853 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64517987 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63932541 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63900837 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63281358 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.61403987 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.61221650 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60166006 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60031599 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.59285021 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.57701686 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56120831 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55980523 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55692328 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55591717 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54949037 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54539754 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54149479 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51680036 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.51401666 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51208788 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50796508 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50432015 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50229166 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.50179569 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48657231 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.48224066 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47984997 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46602325 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46267592 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46158902 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.45833597 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43509904 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41191078 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.40911102 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40639376 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40161080 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39509041 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37937026 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.37863838 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36881635 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36185375 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33971344 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33931431 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32744310 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32736044 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32492655 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32346601 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30821512 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29955305 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.27675590 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27202993 |

